Φορτώνει......
The chemokine interleukin‐8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia
We have identified differentially regulated genes in chronic myeloid leukemia (CML) cells upon short treatment with the broad‐spectrum Bcr–Abl inhibitor dasatinib. The highly specific Bcr–Abl inhibitor nilotinib caused a very similar gene expression signature, validating the identified differentiall...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2008
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527809/ https://ncbi.nlm.nih.gov/pubmed/19383348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.07.003 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|